###### Key questions

What is already known about this subject?
=========================================

-   Constrictive pericarditis is a debilitating disease leading to significant morbidity and mortality. CT provides excellent anatomic assessment of the pericardium prior to surgical planning for pericardiectomy.

-   However, the pattern of pericardial calcium distribution and the association with clinical outcomes are not well described.

What does this study add?
=========================

-   Pericardial calcification was found to be located in a circumferential band-like pattern sparing the basal anterior left ventricle and apical regions of the left and right ventricles, with extension into the mitral and tricuspid annuli in more than 40% of the patients.

-   In this study, a potential protective role of pericardial calcium around the right ventricle was noted, with lower grades of tricuspid regurgitation.

How might this impact on clinical practice?
===========================================

-   Evaluating the distribution of pericardial calcification may aid better understanding of the effect of calcium on regional myocardial mechanics and function.

-   Further studies with a quantitative assessment of pericardial calcification and effect on clinical outcomes are needed.

Introduction {#s1}
============

Constrictive pericarditis (CP) is a debilitating disease caused by a thickened and fibrosed pericardium limiting diastolic filling of the ventricles. It usually results from chronic inflammation due to an initial episode of acute pericarditis as an inciting event. Most common aetiologies in the USA and Europe are a result of idiopathic/viral or postpericardiotomy syndrome whereas in low/middle-income countries, tuberculosis is a prevalent cause.[@R1] Multimodality imaging with echocardiogram (ECHO), cardiac MRI (CMR) and CT is useful to guide the management and diagnosis of CP. The diagnosis of CP can be challenging, therefore algorithms are available to guide the diagnostic approach and need for additional imaging.[@R2] CT provides excellent anatomic assessment of the pericardium and is the preferred imaging modality to assess pericardial calcium (PC) prior to surgical planning.[@R3] Pericardial calcification occurs frequently in CP; however, calcification is not always associated with constriction.[@R4] The impact of pericardial calcification on survival after pericardiectomy has been controversial. Studies have shown pericardial calcification to be an independent predictor of negative perioperative outcomes but no impact on long-term survival.[@R5] However, other studies have shown a negative impact on long-term survival[@R6] highlighting the discrepancy in the consensus on pericardial calcification and long-term survival. The pattern of calcium distribution in CP is not well described and the association between severity of calcification and clinical outcomes has not been evaluated. A PC scoring system has not been established to evaluate the effects of calcium distribution on ECHO variables, surgical, or clinical outcomes in CP.

Methods {#s2}
=======

Patient population {#s2-1}
------------------

This is a retrospective study of patients referred to our centre between 2007 and 2013 with CP who had CT with or without contrast imaging. The diagnosis of CP was confirmed through evidence of constriction on one or more of the following: (A) ECHO, (B) CMR or (C) cardiac catheterisation along with clinical characteristics such as symptoms of right heart failure. Echocardiographic features of constriction included: septal bounce, interventricular dependence, respiratory variation of early mitral inflow velocity \>25% and tricuspid early inflow velocity \>40%, and inferior vena cava (IVC) plethora. Features of constriction on CMR included: pericardial thickening, conical deformity of the ventricles and interventricular dependence. Cardiac catheterisation features of constriction include: elevated right atrial pressures, elevated right ventricle (RV) and left ventricle (LV) end-diastolic pressures with dip and plateau sign, and interventricular dependence.[@R1]

Baseline clinical characteristics, CP aetiology, presurgical New York Heart Association (NYHA) class, medical comorbidities, medications, laboratory values and clinical outcomes were collected and compared between the calcified pericardium and non-calcified pericardium groups. Clinical and imaging data were collected through review of electronic medical record system. Aetiology was divided into idiopathic, infectious, radiation, postpericardiotomy syndrome, trauma, autoimmune, neoplastic or uraemic. The aetiologies were defined based on current definitions and guidelines.[@R1]

Clinical outcomes {#s2-2}
-----------------

Clinical outcomes of all-cause mortality, need for pericardiectomy and surgical outcomes were assessed. All-cause mortality was identified either through use of social security index data or the electronic medical record system. Surgical outcomes were collected at index hospitalisation for all patients who underwent pericardiectomy. Concomitant procedure was defined as coronary artery bypass, valve repair and/or replacement. In-hospital mortality was defined as any patient who died during the initial index hospitalisation. Operative mortality was defined as any patient who died during the index surgery within a 30-day postprocedure period. Readmission within 30 days was reviewed through the use of the electronic medical record system and defined as any admission that required a hospital admission, excluding office visits and emergency department visits.

Calcium scoring {#s2-3}
---------------

We developed a semiquantitative PC scoring system as a measure of pericardial calcification burden to evaluate the distribution of calcium in patients with calcified pericardium. All patients were scanned on standard multidetector CT scanner. PC was identified visually as pericardial segments with high Hounsfield unit. The scoring system allocated calcium into 20 regions named after the corresponding heart structure: the LV and RV were further divided in short axis into four basal, four mid and three apical divisions for the LV and four basal, four mid (both in short axis) divisions and one apical-lateral division (from apical four-chamber view) for the RV ([figures 1 and 2](#F1 F2){ref-type="fig"}). In addition, calcifications in the pericardium surrounding the left and right atria, or extending into the mitral or tricuspid annuli were also noted. PC scores as a measure of pericardial calcification burden were calculated with 1 point given for each involved calcified area. Total PC scores (LV and RV segments only) and regional PC scores (LV, RV, annuli and atria) were then calculated and graphed for each area. Only acceptable CT scans prior to surgery were used for analysis based on the quality of scan to detect calcium in all visualised segments. Patients were excluded if CT scans were not available prior to surgery.

![Constrictive pericarditis patient population. The chart consists of the overall constrictive pericarditis patient population divided into segments excluding patients who did not meet inclusion criteria. This was divided into our total constrictive pericarditis population and further divided into calcified pericardium and non-calcified pericardium groups.](openhrt-2018-000835f01){#F1}

![Spatial distribution of pericardial calcifications. This figure illustrates the frequency of pericardial calcium location corresponding to the various heart structures: left and right atria, mitral and tricuspid annuli, total left ventricle (LV) basal, mid and apical segments, and the total right ventricle (RV) basal, mid and apical segments.](openhrt-2018-000835f02){#F2}

Statistical methods {#s2-4}
-------------------

Statistical analysis was performed using IBM SPSS Statistics V.20.0 (IBM). All continuous variables are expressed as mean±SD and categorical variables as frequency with percentages. P values were obtained for all reported variables and significance defined as p≤0.05. The Shapiro-Wilk test was used to test for normality of continuous variables, with a p value ≤0.05 signifying non-normal data. Continuous variables were also tested for homogeneity of variances using Levene's test for normally distributed data, and analysis of variance for non-normal data, with a p value ≤0.05 signifying unequal variances. For continuous variables, significance was determined using the independent samples t-test, Mann-Whitney U test, or the Mood's median test, depending on normality and variance of the data. The t-test was used on normally distributed data with equal variance and the Welch's t-test statistic was used for normally distributed data with unequal variance. The Mann-Whitney U test was used on non-normal data with equal variance, and the Mood's median test was used on non-normal data with unequal variance. Univariable logistic regression and linear regression models were used to assess predictors of all-cause mortality and total and regional calcium scores on clinical outcomes and echocardiographic variables for patients with PC. Logistic and ordinal (for ranked data) regression models are reported with OR, 95% CIs and p value. Linear regression is reported with correlation coefficient R², beta (β) and p value. Pearson's correlation was used to determine the relationship between LV ejection fraction (LVEF) and total calcium. Correlations are reported with the correlation coefficient R² and corresponding p value.

Results {#s3}
=======

Patient characteristics {#s3-1}
-----------------------

A total of 123 consecutive patients with CP and CT scans available for review were identified through the Cleveland Clinic pericardial database from 2007 to 2013. Patients were classified into calcified pericardium (n=49) and non-calcified pericardium (n=74) groups ([figure 3](#F3){ref-type="fig"}). Baseline clinical characteristics, CP aetiology and clinical outcomes were collected as illustrated in [table 1](#T1){ref-type="table"}. Mean age was 61±13 years (76% male) in overall population. Idiopathic aetiology (48%) was most common and there was no significant difference in aetiologies between the two groups. The use of diuretics, presence of atrial fibrillation and chronic obstructive pulmonary disease (COPD) were significantly higher in the calcified pericardium group. There was no significant difference in age, gender, NYHA class, pericardiectomy or mortality in the two groups.

![Left ventricle (LV) and right ventricle (RV) spatial distribution of pericardial calcifications. This figure illustrates the allocation of pericardial calcium localisation to the 20 areas (LV and RV only) for our semiquantitative scoring system called after the corresponding heart structure: the LV and RV were further divided in short axis into four basal, four mid and three apical divisions for the LV and four basal, four mid (both in short axis) divisions and one apical-lateral division (from apical four-chamber view) for the RV. Segments were then colour coded to illustrate the degree of calcium found in these areas labelled P for pericardium. Ant, anterior; Inf, inferior; L, lateral; RVOT, right ventricle outflow tract.](openhrt-2018-000835f03){#F3}

###### 

Clinical characteristics

  -----------------------------------------------------------------------------------
                                 Overall\    Calcified\   Non-calcified\   P values
                                 (n=123)     (n=49)       (n=74)           
  ------------------------------ ----------- ------------ ---------------- ----------
  Age                            61±13       63±13        59±14            0.073

  Male                           93 (76)     39 (80)      54 (73)          0.403

  All-cause mortality            26 (21)     13 (27)      13 (18)          0.223

  NYHA                                                                     

   I                             13 (11)     3 (6)        10 (14)          0.192

   II                            57 (46)     22 (45)      35 (47)          0.794

   III                           50 (41)     21 (43)      29 (39)          0.685

   IV                            3 (2)       3 (6)        0 (0)            0.061

   Ejection fraction             57±8.1      56.1±8.2     57.5±8.1         0.358

  CP aetiology                                                             

   Idiopathic                    59 (48)     28 (57)      31 (42)          0.097

   Infectious                    4 (3)       0 (0)        4 (5)            0.098

   Radiation                     15 (12)     4 (8)        11 (15)          0.266

   Postpericardiotomy syndrome   31 (25)     14 (29)      17 (23)          0.484

   Trauma                        3 (2)       1 (2)        2 (3)            1

   Autoimmune                    6 (5)       1 (2)        5 (7)            0.401

   Neoplastic                    4 (3)       0 (0)        4 (5)            0.150

   Uraemic                       1 (0.8)     1 (2)        0 (0)            0.398

   Pericardiectomy               64 (52)     30 (61)      34 (46)          0.097

  Comorbidities                                                            

   Hypertension                  71 (58)     25 (51)      46 (62)          0.221

   Hyperlipidaemia               55 (45)     20 (41)      35 (47)          0.479

   Diabetes mellitus             33 (27)     11 (23)      22 (30)          0.372

   CAD                           55 (44)     19 (39)      35 (47)          0.351

   CHF                           59 (48)     27 (55)      32 (43)          0.197

   CKD                           27 (22)     09 (18)      18 (24)          0.435

   Atrial fibrillation           56 (46)     32 (65)      24 (32)          \<0.001

   COPD                          23 (19)     14 (29)      09 (12)          0.022

   Smoking history               72 (59)     33 (67)      39 (53)          0.107

  Medication use                                                           

   Aspirin                       46 (37%)    16 (33%)     30 (41%)         0.376

   Colchicine                    16 (13%)    4 (8%)       12 (16%)         0.194

   NSAID                         20 (16%)    6 (12%)      14 (19%)         0.326

   Steroid                       24 (20%)    6 (12%)      18 (24%)         0.098

   DMARD                         2 (2%)      0            2 (3%)           0.517

   Diuretic                      81 (66%)    39 (80%)     42 (57%)         0.009

  Lab findings\*                                                           

   White cell count              8±3.4       7.6±3.8      8.2±3.1          0.331

   Haemoglobin                   12.2±2.1    12.7±2.1     11.8±2.1         0.019

   Platelets                     226±105     195±82       246±114          0.005

   Sodium                        137.8±3.9   138.4±4.5    137.5±3.5        0.246

   Potassium                     4.1±0.6     4.0±0.6      4.1±0.6          0.388

   Creatinine                    1.3±1.7     1.2±0.8      1.4±2.1          0.554

   Albumin                       3.8±0.6     4±0.6        3.6±0.6          0.002
  -----------------------------------------------------------------------------------

Data were summarised as frequency n (%) for descriptive data and mean±SD for continuous data.

\*Total patients included n=120: 47 in calcified pericardium group and 73 in non-calcified pericardium group.

CAD, coronary artery disease; CHF, congestive heart failure; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; CP, constrictive pericarditis; DMARD, disease-modifying antirheumatic drug; NSAID, non-steroidal anti-inflammatory drug; NYHA, New York Heart Association.

Echocardiographic variables {#s3-2}
---------------------------

Routine ECHO variables were measured between the calcium and non-calcium groups and outlined in [table 2](#T2){ref-type="table"}. Left atrial diameter was larger in calcified group 5.21±0.97 cm vs 4.10±0.95 cm in the non-calcified group (p=0.002); however, left atrial volume index was not statistically significant (p=0.077). There was significantly higher incidence of diastolic septal bounce and larger IVC diameters in the calcified pericardial group versus the non-calcified group (p=0.004, p=0.001). Mitral medial e′ was also higher in the calcified group (p=0.006). There were no other significant differences in echocardiographic parameters between the two groups.

###### 

Echocardiogram data

  ----------------------------------------------------------------------------------------------------------------------------------------
                                                  Overall\                  Calcified\                Non-calcified\            P values
                                                  (n=123)                   (n=49)                    (n=74)                    
  ----------------------------------------------- ------------------------- ------------------------- ------------------------- ----------
  LV end-diastolic dimension, cm (n=84, 27, 57)   4.16±0.76                 4.17±0.67                 4.15±0.80                 0.937

  LV end-systolic dimension, cm (n=81, 25, 56)    2.80 (2.30--3.20)         3.00 (2.40--3.30)         2.70 (2.30--3.13)         0.188

  LV septal thickness, cm\*                       1.00 (0.80--1.20)         1.00 (0.80--1.18)         1.00 (0.80--1.20)         0.591

  LV posterior wall thickness, cm\*               1.00 (0.90--1.10)         1.00 (0.90--1.08)         1.00 (0.90--1.13)         0.724

  LA diameter, cm (n=36, 15, 21)                  4.56±1.10                 5.21±0.97                 4.10±0.95                 0.002

  LA volume index, mL/m^2^ (n=59, 26, 33)         29.40 (22.40--39.00)      31.90 (23.50--42.88)      27.30 (18.50--33.50)      0.077

  LV EDV, mL†                                     84.00 (67.00--105.50)     75.00 (64.00--89.50)      87.50 (68.50--107.50)     0.215

  LV ESV, mL†                                     32.00 (23.00--44.50)      31.00 (22.50--40.50)      35.00 (24.50--44.50)      0.565

  EF, %                                           56.98±8.14                56.14±8.22                57.53±8.10                0.358

  MV E, cm/s (n=99, 38, 61)                       90.00 (75.00--110.75)     86.75 (77.61--112.88)     90.00 (73.00--108.50)     0.599

  \% MV E respiratory change (n=90, 36, 54)       14.43 (5.76--19.79)       16.40 (5.27--18.99)       12.96 (6.87--21.41)       0.814

  MV A, cm/s‡                                     53.24±17.45               48.47±17.46               56.17±16.99               0.071

  MV E/A ratio‡                                   1.73 (1.35--2.18)         1.82 (1.51--2.50)         1.62 (1.30--2.13)         0.133

  Deceleration time, ms§                          148.00 (126.75--174.38)   140.20 (121.13--164.50)   154.00 (138.63--179.13)   0.091

  TV E, cm/s¶                                     61.75 (52.13--69.00)      64.75 (52.75--71.00)      60.50 (51.75--66.00)      0.232

  TV e′ lateral, cm/s (n=48, 16, 32)              10.12±3.64                11.30±3.28                9.53±3.72                 0.083

  \% TV E respiratory change¶                     −35.28±17.41              −34.70±15.09              −35.76±19.33              0.713

  Septal bounce (n=91, 36, 55)                    91 (82)                   36 (97)                   55 (73)                   0.004

  IVC, cm (n=84, 34, 50)                          2.60 (2.28--2.83)         2.80 (2.43--3.00)         2.50 (2.13--2.70)         0.001

  MV e′ medial, cm/s§                             9.00 (8.00--12.00)        10.50 (9.00--14.00)       9.00 (8.00--11.00)        0.006

  MV e′ lateral, cm/s\*\*                         10.00 (8.00--12.25)       11.00 (8.00--14.00)       10.00 (8.00--12.00)       0.068

  Average E/e′ MV (n=87, 34, 53)                  8.65 (6.22--11.81)        8.07 (5.97--11.23)        8.76 (6.88--13.33)        0.130

  Annulus reversus\*\*                            84 (42)                   33 (51.52)                51 (35.29)                0.176
  ----------------------------------------------------------------------------------------------------------------------------------------

Data were summarised as frequency n (%) for descriptive data and mean±SD for continuous data.

Total patients in each group where n = total, calcified, non-calcified group: \*(n=82,26,56), †(n=55,19,36), ‡(n=71,27,44), §(88,34,54), ¶(62,28,34), \*\*(84,33,51).

EDV, end-diastolic volume; EF, ejection fraction; ESV, end-systolic volume; IVC, inferior vena cava; LA, left atrium; LV, left ventricle; MV, mitral valve; TV, tricuspid valve.

Surgical data {#s3-3}
-------------

Surgical outcomes were collected at index hospitalisation for all patients who underwent pericardiectomy as outlined in [table 3](#T3){ref-type="table"}. Of the 64 patients, there were 2 (3%) in hospital mortality and 1 (2%) operative mortality. Five patients (8%) did not have follow-up at 30 days, but had phone follow-up \<30 days. There was no significant difference in the surgical outcomes between the two groups.

###### 

Surgical data and outcomes

  ---------------------------------------------------------------------------------
                                Overall\   Calcified\   Non-calcified\   P values
                                (n=64)     (n=30)       (n=34)           
  ----------------------------- ---------- ------------ ---------------- ----------
  Surgery approach                                                       

   Median sternotomy            53 (83%)   26 (87%)     27 (79%)         0.443

   Anterior thoracotomy         11 (17%)   4 (13%)      7 (21%)          0.443

   Redo sternotomy              18 (28%)   6 (20%)      12 (35%)         0.174

   Use of CPB                   46 (72%)   22 (73%)     24 (71%)         0.807

   Concomitant procedure        26 (41%)   10 (33%)     16 (47%)         0.265

  Surgical outcomes                                                      

   LOS \>5 days                 60 (94%)   30 (100%)    30 (88%)         0.116

   In-hospital mortality        2 (3%)     1 (3%)       1 (3%)           1

   Operative mortality          1 (2%)     1 (3%)       0                0.47

   ICU stay \>8 days            8 (13%)    5 (17%)      3 (9%)           0.458

   Readmission within 30 days   8 (13%)    5 (17%)      3 (9%)           0.458

   Reoperation for bleeding     3 (5%)     2 (7%)       1 (3%)           0.596
  ---------------------------------------------------------------------------------

Data were summarised as frequency n (%) for descriptive data and mean±SD for continuous data.

CPB, cardiopulmonary bypass; ICU, intensive care unit; LOS, length of stay (in days).

Calcium scoring {#s3-4}
---------------

PC spatial distribution for the calcified pericardium group is illustrated in [figure 1](#F1){ref-type="fig"}. [Figure 2](#F2){ref-type="fig"} further illustrates pericardial spatial distribution within the LV and RV basal, mid and apical regions. Calcium involvement of the LV basal anterior, mid-anterior and apical segments in addition to RV apical segment was involved in \<30% of the cases. The remaining segments were involved in \>35% of cases. Of note, 51% and 41% had PC extending into the mitral and tricuspid annuli. Two of the 49 patients in the calcified pericardium group had calcium localised to the atria or LV apical cap.

[Tables 4 and 5](#T4 T5){ref-type="table"} illustrate the univariable logistic regression and linear regression models used to assess predictors of all-cause mortality and effect of different variables on total PC scores. Total PC scores and regional PC scores (LV, RV and annuli) were used to assess predictors of clinical outcomes and echocardiographic variables. The multinomial logistic regression model showed that albumin and NYHA play a significant role in predicting all-cause mortality with higher albumin scores associated with lower mortality and higher NYHA associated with higher mortality. The linear regression model showed that with higher RV scores, % respiratory change in tricuspid valve decreased (R²=0.149, β=−2.072, p=0.043) and tricuspid regurgitation grade also decreased (OR=0.743, p=0.008). There was no significant correlation between LVEF and total calcium (R²=−0.044, p=0.764).

###### 

Univariable logistic regression

  Independent variables   Dependent variables   OR                  95%CI               P values
  ----------------------- --------------------- ------------------- ------------------- ----------
  Total PC score          Death                 0.935               (0.807 to 1.084)    0.373
  NYHA                    0.959                 (0.851 to 1.082)    0.498               
  Pericardiectomy         1.033                 (0.907 to 1.176)    0.624               
  NYHA                    Death                 3.946               (1.468 to 10.608)   0.007
  Ejection fraction       0.960                 (0.904 to 1.020)    0.188               
  Age                     1.028                 (0.981 to 1.077)    0.242               
  Albumin                 0.305                 (0.127 to 0.735)    0.008               
  Sodium                  1.003                 (0.881 to 1.142)    0.963               
  Total LV scores         MR grade              0.891               (0.736 to 1.079)    0.236
  Annulus reversus        1.258                 (0.979 to 1.617)    0.073               
  Total RV scores         TR grade              0.743               (0.597 to 0.926)    0.008
  Mitral annulus          MR grade              0.868               (0.261 to 2.888)    0.817
  Annulus reversus        3.086                 (0.734 to 12.981)   0.124               
  Tricuspid annulus       TR grade              2.568               (0.736 to 8.965)    0.139

LV, left ventricle; MR, mitral regurgitation; NYHA, New York Heart Association; PC, pericardial calcium; RV, right ventricle; TR, tricuspid regurgitation.

###### 

Linear regression

  Independent variables   Dependent variables   R²       β        P values
  ----------------------- --------------------- -------- -------- ----------
  Total LV scores         MV E                  0.047    −1.832   0.190
  \% respiratory MV E     0.005                 0.230    0.675    
  MV E/A ratio            0.001                 −0.014   0.895    
  DT                      0.017                 1.711    0.461    
  MV e′ medial            0.034                 0.253    0.294    
  MV e′ lateral           0.035                 −0.254   0.300    
  Average E/e′ MV         0.004                 −0.076   0.731    
  Total RV scores         TV E                  0.054    −2.246   0.234
  TV e′ lateral           0.048                 0.320    0.415    
                          \% respiratory TV E   0.149    −2.072   0.043
  Age                     Total PC score        0.012    −0.037   0.463
  Gender                  0.012                 1.236    0.445    
  Smoking                 0.006                 0.737    0.597    
  Creatinine              0.062                 −1.337   0.092    
  Albumin                 0.004                 −0.464   0.680    
  Body mass index         0.062                 0.176    0.210    

\% resp, percent respiratory variation; A, peak late mitral diastolic flow velocity; DT, deceleration time; E, peak early diastolic flow velocity; e', early mitral annular tissue diastolic velocity; LV, left ventricle; MV, mitral valve; PC, pericardial calcium; R^2^, correlation coefficient; RV, right ventricle; TV, tricuspid valve.

Discussion {#s4}
==========

The results of our study show the preferential distribution of calcium in CP in a partial band-like pattern (from basal anterolateral LV going inferiorly and then encircling the heart to reach the RV outflow tract) with extension into the mitral and tricuspid annuli. Calcium involvement of the pericardial segments corresponding to the LV basal anterior, mid-anterior and apical segments in addition to RV apical segment was involved in \<30% of the cases. The remaining segments were involved in \>35% of cases. Once pericardial calcifications are present, \>40% of patients will have pericardial calcifications extending into either the mitral or tricuspid annuli. Several studies have investigated perioperative complications and outcomes after pericardiectomy.[@R7] In our cohort, there was no significant difference in surgical outcomes between the calcified and non-calcified pericardium groups.

As in previous studies, idiopathic CP was the most common aetiology in our study.[@R9] Higher diuretic use, incidence of atrial fibrillation, COPD, larger atria and IVC diameters were also found in the calcified pericardium group, suggesting a more chronic and symptomatic patient population. The distribution of pericardial calcifications has been described in other case reports and small studies, but has not been evaluated in a similar sized case series.[@R11] The relative sparing of the pericardial segments corresponding to the basal anterior LV and apical segments with significant involvements of the other segments brings out two questions[@R1]: what is the mechanism favouring this pattern of calcium deposition, and[@R2] how does this impact the mechanics of the heart. However, we believe that pericardial calcification can be viewed as the end product of chronic inflammation. In our study, aspirin use was associated with lower total PC scores, suggesting perhaps the important role for anti-inflammatory therapy in this process. Thus, the calcified parts are the most affected and if the innervation of the heart plays a role in the aetiology of the insult then this calcification pattern follows the heart innervation pattern. Alternatively, we cannot exclude a simple dependent mechanism of inflammatory material that follows the patients being in a supine position. This, however, will not explain the RV outflow tract involvement. Studies have shown that patients with CP have lower lateral annulus tissue Doppler compared with the medial annulus, referred to as 'annulus reversus'.[@R16] This finding parallels the increased calcium involvement of the pericardial segments corresponding to the lateral wall often extending into the mitral annulus, thereby limiting lateral annular velocity due to tethering from fibrotic or calcified pericardium. Further, higher RV calcium scores were shown to have lower grades of tricuspid regurgitation and lower respiratory variation, suggesting perhaps a protective role of RV calcium with regional mechanics.

Pericardial calcification's impact on survival has been controversial with some studies showing a negative impact on survival and others showing no impact.[@R5] In our study, clinical outcomes of mortality and pericardiectomy between the two groups were not found to be statistically significant and total PC score did not significantly predict clinical outcomes. Previous studies have shown poor surgical outcomes with advanced NYHA, radiation aetiology, chronic lung disease with renal failure, use of cardiopulmonary bypass and previous cardiac surgery to be predictors of worse outcomes.[@R7] In our study, the presence of calcium did not significantly predict adverse surgical outcomes or all-cause mortality. The number included in the cohort may explain the absence of statistical association.

Study limitations {#s4-1}
-----------------

This is a retrospective study at a single institution with a relatively small sample size, therefore limiting power and introducing potential selection bias. The retrospective design, lack of a true quantitative method to assess PC and limited follow-up clinical data could have limited identifying associations with outcomes and any competing risks between mortality and surgery between the two groups. Moreover, not all included patients had CT data amenable for analysis reducing our sample size significantly. Also, not all ECHO data were amenable for analysis limiting the association we can make between calcium and different ECHO variables. Echocardiographic data were collected at rest, therefore the effect of pericardial calcification on regional RV and LV haemodynamic changes with exercise is not available. In addition, providing a quantitative assessment of calcium severity may have been a more rigorous approach. This is highly appreciated as it is not reasonable to assume that the value of a speckle or two of calcium in a pericardial segment is equivalent to dense large chunks of calcifications in another segment. This is a limitation of our semiquantitative scoring system. Unfortunately, solving this predicament was not possible due to inherent limitations in the calcium scoring software designed initially for coronary calcification and not pericardial calcification. Two examples of these limitations are[@R1]: numerous patients had calcifications that were continuous from one pericardial segment to another, especially in the basal LV inferior and basal RV inferior segments, which made splitting the calcifications by the software not feasible; and[@R2] the range of values obtained because of the density of the calcifications reached in some cases beyond 30 000 Agatston score which extrapolates this system into numerical values not encountered in the coronaries and thus presented a theoretical challenge. Thus, we limited our data analysis to semiquantitative methods of PC scoring, pending development of a more scientifically acceptable method to quantify pericardial calcifications. Future studies addressing the association of distribution of PC with clinical outcomes, myocardial atrophy and ECHO data need to be also further investigated. Also important is the effectiveness of medical therapy in the presence and severity of pericardial calcification.

Conclusion {#s5}
==========

Our study demonstrates the spatial distribution of pericardial calcification and correlation between calcium and clinical outcomes. Pericardial calcification was found to be located in a circumferential band sparing the basal anterior LV segment and apical regions of the LV and RV. In more than 40% of patients with pericardial calcifications these calcifications extended into the mitral or tricuspid annuli. Our results showed that the presence of calcium did not significantly predict surgical outcomes and the total PC score did not significantly predict clinical outcomes. A potential protective role of RV calcium in regional myocardial mechanics was observed. Further studies with a quantitative assessment of PC and association with clinical outcomes are needed.
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